Literature DB >> 35719210

Productivity and quality improvement for a symmetric bispecific antibody through the application of intensified perfusion cell culture.

Yongjun Qin1, Rongmei Ma1, Yang Li1, Yifeng Li1, Gong Chen1, Weichang Zhou2.   

Abstract

Background: Aggregation, fragmentation, and low yield are issues frequently found during the cell culture process of bispecific antibodies (bsAbs), whose inherent complexity likely plays a role in causing these issues.
Methods: In this study, we made a head-to-head comparison between fed-batch cell culture and intensified perfusion cell culture with a symmetric bsAb case.
Results: In comparison with the fed-batch culture, a 6.6-fold improvement in integrated viable cell density and a 10.9-fold improvement in volumetric productivity were achieved with the intensified perfusion mode. In addition, a significant decrease in aggregation and fragmentation was observed with the intensified perfusion cell culture. Furthermore, product homogeneity was improved, which was reflected by the increased percentage of capillary isoelectric focusing main group. The quality improvement with intensified perfusion cell culture can be attributed to the shortened product retention in the bioreactor. Conclusions: These findings suggest that intensified perfusion cell culture could be a better choice than traditional fed-batch especially for complex molecules like bsAbs. As this is a single case report, future studies on other cases are needed to further confirm the general applicability of this strategy.
© The Author(s) 2022. Published by Oxford University Press on behalf of Antibody Therapeutics. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  aggregation; bispecific antibody (bsAb); fragmentation; intensified perfusion; volumetric productivity (Pv)

Year:  2022        PMID: 35719210      PMCID: PMC9199187          DOI: 10.1093/abt/tbac009

Source DB:  PubMed          Journal:  Antib Ther        ISSN: 2516-4236


  20 in total

1.  Uncoupling of cell growth and proliferation results in enhancement of productivity in p21CIP1-arrested CHO cells.

Authors:  Jing-Xiu Bi; John Shuttleworth; Mohamed Al-Rubeai
Journal:  Biotechnol Bioeng       Date:  2004-03-30       Impact factor: 4.530

2.  Monoclonal antibody successes in the clinic.

Authors:  Janice M Reichert; Clark J Rosensweig; Laura B Faden; Matthew C Dewitz
Journal:  Nat Biotechnol       Date:  2005-09       Impact factor: 54.908

3.  Perfusion cell culture for the production of conjugated recombinant fusion proteins reduces clipping and quality heterogeneity compared to batch-mode processes.

Authors:  Jean-Marc Bielser; Loïc Chappuis; Yashi Xiao; Jonathan Souquet; Hervé Broly; Massimo Morbidelli
Journal:  J Biotechnol       Date:  2019-06-15       Impact factor: 3.307

4.  Larger Pore Size Hollow Fiber Membranes as a Solution to the Product Retention Issue in Filtration-Based Perfusion Bioreactors.

Authors:  Samantha B Wang; Scott Godfrey; Flaka Radoniqi; Henry Lin; Jon Coffman
Journal:  Biotechnol J       Date:  2018-12-13       Impact factor: 4.677

Review 5.  Perfusion mammalian cell culture for recombinant protein manufacturing - A critical review.

Authors:  Jean-Marc Bielser; Moritz Wolf; Jonathan Souquet; Hervé Broly; Massimo Morbidelli
Journal:  Biotechnol Adv       Date:  2018-05-05       Impact factor: 14.227

6.  Intracellular CHO Cell Metabolite Profiling Reveals Steady-State Dependent Metabolic Fingerprints in Perfusion Culture.

Authors:  Daniel J Karst; Robert F Steinhoff; Marie R G Kopp; Elisa Serra; Miroslav Soos; Renato Zenobi; Massimo Morbidelli
Journal:  Biotechnol Prog       Date:  2017-03-03

Review 7.  Bispecific monoclonal antibodies for targeted immunotherapy of solid tumors: Recent advances and clinical trials.

Authors:  Seyed Samad Hosseini; Saeed Khalili; Behzad Baradaran; Negar Bidar; Mohammad-Ali Shahbazi; Jafar Mosafer; Mahmoud Hashemzaei; Ahad Mokhtarzadeh; Michael R Hamblin
Journal:  Int J Biol Macromol       Date:  2020-11-14       Impact factor: 6.953

8.  Improving an intensified and integrated continuous bioprocess platform for biologics manufacturing.

Authors:  Hang Zhou; Mingyue Fang; Xiang Zheng; Weichang Zhou
Journal:  Biotechnol Bioeng       Date:  2021-04-14       Impact factor: 4.530

Review 9.  Evolving trends in mAb production processes.

Authors:  Abhinav A Shukla; Leslie S Wolfe; Sigma S Mostafa; Carnley Norman
Journal:  Bioeng Transl Med       Date:  2017-04-03

10.  The relationship between mTOR signalling pathway and recombinant antibody productivity in CHO cell lines.

Authors:  Raihana Edros; Susan McDonnell; Mohamed Al-Rubeai
Journal:  BMC Biotechnol       Date:  2014-02-17       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.